Imunon, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-20.4M | $-22.1M | $-22.5M | $-25.5M | $-8.3M | $-26.6M | $-23.2M | $-18.8M |
| Depreciation & Amortization | $553.0K | $1.0M | $425.0K | $369.3K | $339.2K | $281.5K | $169.4K | $165.5K |
| Depreciation | $326.0K | $455.0K | $425.0K | $369.0K | $339.0K | $281.5K | $169.0K | $165.0K |
| Amortization | $227.3K | $5.6K | $7.5K | $7.5K | $7.5K | $7.5K | $7.5K | $7.5K |
| Stock-Based Compensation | $1.1M | $1.5M | $1.8M | $2.6M | $1.2M | $1.1M | $1.0M | $1.3M |
| Net Cash from Operating Activities | $-16.6M | $-18.4M | $-20.8M | $-21.4M | $-9.5M | $-22.1M | $-22.7M | $-13.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $38.6K | $62.5K | $109.3K | $672.3K | $57.5K | $613.4K | $573.4K | $6.7K |
| Business Acquisitions | — | — | — | $2.8M | — | — | — | — |
| Net Cash from Investing Activities | $-11.0M | $9.1M | $13.3M | $9.5M | $-29.1M | $1.5M | $-11.1M | $5.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $36.5M | $2.7M | $4.1M | $18.8M | $29.4M | $15.5M | $52.8M | $2.4M |
| Net Change in Cash | $8.8M | $-6.6M | $-3.4M | $7.0M | $-9.3M | $-5.2M | $19.0M | $-5.8M |
| Free Cash Flow | $-16.7M | $-18.4M | $-20.9M | $-22.0M | $-9.6M | $-22.8M | $-23.3M | $-13.4M |